Immunovant, Inc. IMVT Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s other income, net (note 6)?
- Immunovant, Inc. (IMVT) reported other income, net (note 6) of $798K in Q1 2026.
- How has Immunovant, Inc.'s other income, net (note 6) changed year-over-year?
- Immunovant, Inc.'s other income, net (note 6) decreased by 25.5% year-over-year, from $1.07M to $798K.
- What is the long-term trend for Immunovant, Inc.'s other income, net (note 6)?
- Over 3 years (2022 to 2026), Immunovant, Inc.'s other income, net (note 6) has grown at a 38.3% compound annual growth rate (CAGR), from -$824K to $2.18M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.